Ryder Steven
SEC insider (Form 3/4/5 filer). CIK 0001872868. Chief Medical Officer at Yarrow Bioscience, Inc. (YARW) and 2 other issuers. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in CARMEL, IN.
Companies Ryder Steven has filed insider reports for
- Yarrow Bioscience, Inc. (YARW): Officer, Chief Medical Officer
- MBX Biosciences, Inc. (MBX): Director
- Rallybio Corp (RLYB): Officer, Chief Medical Officer
Ryder Steven
CIK: 0001872868
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 4, 2026MBX
MBX Biosciences, Inc.
AwardDirectStock option (right to buy)
12.5K shares- - Jun 5, 2025MBX
MBX Biosciences, Inc.
AwardDirectStock option (right to buy)
16K shares- - Feb 14, 2025RLYB
Rallybio Corp
AwardDirectOption (Right to Buy)
180K shares- - Sep 12, 2024MBX
MBX Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
16K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 |  MBX MBX Biosciences, Inc. | Award Stock option (right to buy) | 12,500 | - | - | Direct |
| Jun 5, 2025 | MBX MBX Biosciences, Inc. | Award Stock option (right to buy) | 16,000 | - | - | Direct |
| Feb 14, 2025 |  RLYB Rallybio Corp | Award Option (Right to Buy) | 180,000 | - | - | Direct |
| Sep 12, 2024 | MBX MBX Biosciences, Inc. | Award Stock Option (Right to Buy) | 15,963 | - | - | Direct |
1-4 of 4 transactions